Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 août 2019 16h15 HE | Source: Adaptive Biotechnologies

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019

SEATTLE, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the second quarter of 2019 after market close on Tuesday,...
31 juil. 2019 16h15 HE | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers

SEATTLE, July 31, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the...
01 juil. 2019 16h05 HE | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

SEATTLE, July 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the...
26 juin 2019 19h57 HE | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Announces Pricing of Initial Public Offering

SEATTLE, June 26, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the...